Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles

Damien Kudela, Anna May-Masnou, Stephanie A. Smith, Gary Braun, Alessia Pallaoro, Tracy Chuong, James H. Morrissey, Galen D. Stucky

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Trauma-induced hemorrhage remains a leading cause of preventable death. Silica nanoparticles (SNPs) - long known for their procoagulant properties - have recently been used as a first-response treatment. Functionalizing SNPs with polyphosphate (polyP) - analogous to the polyP produced by activated platelets to induce clotting - to form SNP-polyP leads to decreased clotting times. The decrease in clotting time is even more apparent when studied under traumatic conditions such as hemodilution and hypothermia. In addition to external treatment, the SNP-polyP particles can be protected with polyethylene glycol (PEG) and targeted to treat internal hemorrhage.

Original languageEnglish (US)
Title of host publicationTechnical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Pages361-364
Number of pages4
StatePublished - Aug 9 2013
EventNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013 - Washington, DC, United States
Duration: May 12 2013May 16 2013

Publication series

NameTechnical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Volume3

Other

OtherNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
CountryUnited States
CityWashington, DC
Period5/12/135/16/13

Fingerprint

Polyphosphates
Silicon Dioxide
Nanoparticles
Hemorrhage
Hemodilution
Hypothermia
Cause of Death
Blood Platelets
Wounds and Injuries
Therapeutics

Keywords

  • Drug delivery
  • Hemorrhage
  • Lethal triad
  • Polyphosphate
  • Silica nanoparticles

ASJC Scopus subject areas

  • Biotechnology

Cite this

Kudela, D., May-Masnou, A., Smith, S. A., Braun, G., Pallaoro, A., Chuong, T., ... Stucky, G. D. (2013). Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles. In Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013 (pp. 361-364). (Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013; Vol. 3).

Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles. / Kudela, Damien; May-Masnou, Anna; Smith, Stephanie A.; Braun, Gary; Pallaoro, Alessia; Chuong, Tracy; Morrissey, James H.; Stucky, Galen D.

Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. 2013. p. 361-364 (Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013; Vol. 3).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Kudela, D, May-Masnou, A, Smith, SA, Braun, G, Pallaoro, A, Chuong, T, Morrissey, JH & Stucky, GD 2013, Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles. in Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013, vol. 3, pp. 361-364, Nanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013, Washington, DC, United States, 5/12/13.
Kudela D, May-Masnou A, Smith SA, Braun G, Pallaoro A, Chuong T et al. Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles. In Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. 2013. p. 361-364. (Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013).
Kudela, Damien ; May-Masnou, Anna ; Smith, Stephanie A. ; Braun, Gary ; Pallaoro, Alessia ; Chuong, Tracy ; Morrissey, James H. ; Stucky, Galen D. / Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles. Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. 2013. pp. 361-364 (Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013).
@inproceedings{304ecbdbe24c484396ef1e4a8b48a98a,
title = "Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles",
abstract = "Trauma-induced hemorrhage remains a leading cause of preventable death. Silica nanoparticles (SNPs) - long known for their procoagulant properties - have recently been used as a first-response treatment. Functionalizing SNPs with polyphosphate (polyP) - analogous to the polyP produced by activated platelets to induce clotting - to form SNP-polyP leads to decreased clotting times. The decrease in clotting time is even more apparent when studied under traumatic conditions such as hemodilution and hypothermia. In addition to external treatment, the SNP-polyP particles can be protected with polyethylene glycol (PEG) and targeted to treat internal hemorrhage.",
keywords = "Drug delivery, Hemorrhage, Lethal triad, Polyphosphate, Silica nanoparticles",
author = "Damien Kudela and Anna May-Masnou and Smith, {Stephanie A.} and Gary Braun and Alessia Pallaoro and Tracy Chuong and Morrissey, {James H.} and Stucky, {Galen D.}",
year = "2013",
month = "8",
day = "9",
language = "English (US)",
isbn = "9781482205862",
series = "Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013",
pages = "361--364",
booktitle = "Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013",

}

TY - GEN

T1 - Reversing coagulopathy and internal hemorrhage with functionalized nanoparticles

AU - Kudela, Damien

AU - May-Masnou, Anna

AU - Smith, Stephanie A.

AU - Braun, Gary

AU - Pallaoro, Alessia

AU - Chuong, Tracy

AU - Morrissey, James H.

AU - Stucky, Galen D.

PY - 2013/8/9

Y1 - 2013/8/9

N2 - Trauma-induced hemorrhage remains a leading cause of preventable death. Silica nanoparticles (SNPs) - long known for their procoagulant properties - have recently been used as a first-response treatment. Functionalizing SNPs with polyphosphate (polyP) - analogous to the polyP produced by activated platelets to induce clotting - to form SNP-polyP leads to decreased clotting times. The decrease in clotting time is even more apparent when studied under traumatic conditions such as hemodilution and hypothermia. In addition to external treatment, the SNP-polyP particles can be protected with polyethylene glycol (PEG) and targeted to treat internal hemorrhage.

AB - Trauma-induced hemorrhage remains a leading cause of preventable death. Silica nanoparticles (SNPs) - long known for their procoagulant properties - have recently been used as a first-response treatment. Functionalizing SNPs with polyphosphate (polyP) - analogous to the polyP produced by activated platelets to induce clotting - to form SNP-polyP leads to decreased clotting times. The decrease in clotting time is even more apparent when studied under traumatic conditions such as hemodilution and hypothermia. In addition to external treatment, the SNP-polyP particles can be protected with polyethylene glycol (PEG) and targeted to treat internal hemorrhage.

KW - Drug delivery

KW - Hemorrhage

KW - Lethal triad

KW - Polyphosphate

KW - Silica nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84881092924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881092924&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84881092924

SN - 9781482205862

T3 - Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013

SP - 361

EP - 364

BT - Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013

ER -